Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- RWA
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Horizon Sopyrwa Ltd | Plot No: 4, Street Number: MN 159, Musanze, 0000, Rwanda (RWA) | Active ingredient (API) manufacture | 3014485739850554289 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | pyrethrum extract | liquid | 72273-364DRUG FOR FURTHER PROCESSING |
Enquiry
Common questions
- Is Horizon Sopyrwa Ltd FDA approved?
- Horizon Sopyrwa Ltd holds 1 FDA-registered establishment in RWA. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Horizon Sopyrwa Ltd's drugs manufactured?
- The FDA register lists Musanze. Registered operations: active ingredient (API) manufacture.
- What drugs does Horizon Sopyrwa Ltd make?
- 1 product is listed under Horizon Sopyrwa Ltd in the openFDA NDC Directory, most often as liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.